Form 4: Innoviva Director Jules Haimovitz Reports Stock and Option Grant

Director Jules Haimovitz reports acquisition of Innoviva stock and options following the company's 2025 annual meeting of stockholders.

Summary

• Jules Haimovitz, a director of Innoviva, Inc., filed a Form 4 on May 21, 2025, reporting changes in beneficial ownership.
• On May 19, 2025, Haimovitz acquired 12,077 shares of common stock and options for 10,000 shares as part of a grant.
• The restricted stock units (RSUs) and options were granted upon the conclusion of Innoviva's 2025 annual meeting of stockholders.
• 100% of the RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to continuous service as an Outside Director.
• Following the reported transaction, Haimovitz beneficially owns 142,906 shares of common stock and options for 10,000 shares.
• The exercise price for the non-statutory stock options is $18.63, and they expire on May 18, 2035.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock and options to a director, which is generally viewed as a neutral to slightly positive event as it aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of stock and options to a director aligns their interests with those of the shareholders.
• The vesting schedule incentivizes continued service as an Outside Director.

Future Outlook

The RSUs and options will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates compensation in the form of equity to a board member, which is a common practice.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across publicly traded companies.
• The vesting schedule of one year or the next annual meeting is also typical to align director interests with shareholder value.
• Comparing the size of the grant to similar companies would require further analysis of Innoviva's compensation policies and peer group data.

Stakeholder Impact

• Shareholders may view the equity grant as a positive sign, aligning the director's interests with the company's long-term success.
• The director is incentivized to continue serving on the board and contributing to the company's performance.

Key Dates

Keywords

Form 4, Beneficial Ownership, Director, Innoviva, INVA, Stock Options, Restricted Stock Units, RSUs, Vesting